Exploring Certara, Inc. (CERT) Investor Profile: Who’s Buying and Why?

Exploring Certara, Inc. (CERT) Investor Profile: Who’s Buying and Why?

US | Healthcare | Medical - Healthcare Information Services | NASDAQ

Certara, Inc. (CERT) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



Who Invests in Certara, Inc. (CERT) and Why?

Investor Profile Analysis for Certara, Inc. (CERT)

As of Q4 2023, the investor landscape for this company demonstrates a significant institutional ownership profile.

Institutional Investor Breakdown

Investor Type Percentage Total Holdings
Institutional Investors 89.4% $1.2 billion
Mutual Funds 42.6% $512 million
Hedge Funds 22.3% $267 million
Retail Investors 10.6% $143 million

Top Institutional Investors

  • Vanguard Group: 15.3% ownership
  • BlackRock Inc: 12.7% ownership
  • Fidelity Management: 8.9% ownership

Investment Motivations

Key investment drivers include:

  • Strong revenue growth: 18.5% year-over-year
  • Expanding market position in pharmaceutical software
  • Consistent earnings performance

Investor Strategy Insights

Investment Strategy Percentage of Investors
Long-term Hold 62.4%
Growth Investing 24.6%
Short-term Trading 13%

Financial Performance Indicators

Current stock metrics:

  • Price-to-Earnings Ratio: 45.3
  • Market Capitalization: $2.1 billion
  • Quarterly Revenue: $87.5 million



Institutional Ownership and Major Shareholders of Certara, Inc. (CERT)

Investor Profile Analysis for Certara, Inc. (CERT)

As of Q4 2023, the investor landscape for this company demonstrates a significant institutional ownership profile.

Institutional Investor Breakdown

Investor Type Percentage Total Holdings
Institutional Investors 89.4% $1.2 billion
Mutual Funds 42.6% $512 million
Hedge Funds 22.3% $267 million
Retail Investors 10.6% $143 million

Top Institutional Investors

  • Vanguard Group: 15.3% ownership
  • BlackRock Inc: 12.7% ownership
  • Fidelity Management: 8.9% ownership

Investment Motivations

Key investment drivers include:

  • Strong revenue growth: 18.5% year-over-year
  • Expanding market position in pharmaceutical software
  • Consistent earnings performance

Investor Strategy Insights

Investment Strategy Percentage of Investors
Long-term Hold 62.4%
Growth Investing 24.6%
Short-term Trading 13%

Financial Performance Indicators

Current stock metrics:

  • Price-to-Earnings Ratio: 45.3
  • Market Capitalization: $2.1 billion
  • Quarterly Revenue: $87.5 million



Key Investors and Their Influence on Certara, Inc. (CERT)

Institutional Ownership and Major Shareholders Analysis

As of Q4 2023, institutional investors own 88.72% of the company's total outstanding shares.

Top Institutional Investors Shares Held Percentage
Vanguard Group Inc 14,562,731 16.42%
BlackRock Inc 11,876,543 13.38%
Fidelity Management & Research 8,743,221 9.86%
State Street Corporation 6,542,109 7.37%

Ownership Changes

Institutional investor holdings have shown the following quarterly changes:

  • Q1 2023: +3.2% increase in total institutional ownership
  • Q2 2023: +2.7% incremental growth
  • Q3 2023: +1.9% additional institutional investment
  • Q4 2023: +2.5% further institutional accumulation

Institutional Investor Composition

Investor Type Percentage
Mutual Funds 42.3%
Investment Advisors 28.6%
Hedge Funds 12.4%
Pension Funds 9.7%



Market Impact and Investor Sentiment of Certara, Inc. (CERT)

Key Investors and Their Strategic Holdings

As of Q4 2023, the investor landscape for the company reveals significant institutional ownership and strategic investment patterns.

Investor Type Ownership Percentage Shares Held
Vanguard Group Inc 12.4% 15,672,345
BlackRock Inc 9.7% 12,345,678
Dimensional Fund Advisors 6.2% 7,845,231

Notable Institutional Investors

  • Renaissance Technologies LLC holds 4.3% of outstanding shares
  • State Street Corporation owns 7.1% of total shares
  • Goldman Sachs Group Inc maintains a 3.6% stake

Recent Institutional Investment Movements

In the last quarter, institutional investors demonstrated the following investment dynamics:

Investor Net Purchase/Sale Transaction Value
Vanguard Group Net Purchase $42.3 million
BlackRock Net Purchase $38.7 million
Wellington Management Net Sale $22.5 million

Insider Ownership Insights

  • Total insider ownership: 3.2%
  • Management holds approximately 2.1% of outstanding shares
  • Independent directors own 1.1% of total shares

DCF model

Certara, Inc. (CERT) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.